Health and Medicine
Sep. 22, 2020—Vanderbilt researchers have been awarded $500,000 by Google’s philanthropic arm, Google.org, to study how COVID-19 alters gene expression in some people in ways that may be linked to to their risk of severe illness and death.
Sep. 20, 2020—Researchers at Vanderbilt University Medical Center have identified antibodies that, in animals, block infection by alphaviruses, which can cause chronic and debilitating joint pain and arthritis and are an increasing global health concern.
Sep. 20, 2020—Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19.
Sep. 20, 2020—A small-molecule “scavenger” that reduces inflammation and formation of atherosclerotic plaque in blood vessels in mice potentially could lead to a new approach for treating atherosclerosis in humans, according to researchers at Vanderbilt University Medical Center.
International collaboration with Vanderbilt scientists sheds light on rare exocyst mutations that cause severe developmental disabilities in children
Sep. 14, 2020—Mukhtar Ahmed, Christian de Caestecker and Ian Macara, in collaboration with geneticists from Australia and Italy discover novel mutations in the Exocyst, providing new understanding of a critical cellular protein complex.
Sep. 11, 2020—A new $2.5 million grant from the National Institutes of Health is enabling Vanderbilt University chemist Renã A.S. Robinson to expand her research on racial disparities in Alzheimer’s and other diseases.
Sep. 11, 2020—Derek Griffith, professor of medicine, health and society and founding director of the Center for Research on Men’s Health, takes an intersectional approach to researching the impacts of COVID-19, advocating for a more nuanced understanding of identity’s role in determining risk to enhance policy reforms toward greater health equity.
Vanderbilt team works across disciplines to replicate cellular filament behavior for the first time, shedding new light on a fundamental cellular process
Sep. 8, 2020—Cell biologists, physicists and computer scientists use computational modeling to pinpoint the components that shape cell behavior.
Aug. 28, 2020—Single-cell and multisystem analysis leads cell biologists at Vanderbilt to new understanding of rare cells, with potential inflammation-reducing therapeutics for Crohn’s disease and IBD patients.
Aug. 27, 2020—Taking an interest in electronic message threads between surgical patients and their health care teams, a research group at Vanderbilt University Medical Center has tested how well certain commonly used machine learning algorithms can classify such exchanges according to their clinical decision-making complexity.
Aug. 19, 2020—While 60 percent of people with metastatic melanoma, an aggressive type of skin cancer, have multiple treatment options available to them, roughly 40 percent either do not respond to treatment, or relapse.
Aug. 19, 2020—A bifunctional natural compound has been discovered with the potential to make antibiotic resistance to deadly infections less likely.